Literature DB >> 15022313

Clustering of disease features within 512 multicase rheumatoid arthritis families.

Damini Jawaheer1, Raymond F Lum, Christopher I Amos, Peter K Gregersen, Lindsey A Criswell.   

Abstract

OBJECTIVE: To determine whether specific rheumatoid arthritis (RA) disease features demonstrate the presence of significant familial clustering.
METHODS: We studied 1,097 individuals with RA from 512 multicase families enrolled in the North American Rheumatoid Arthritis Consortium. All patients were interviewed and examined to collect standardized information about demographic and clinical characteristics. Affected individuals also underwent radiography of the hands and wrists and were genotyped for the HLA-DRB1 shared epitope. Familial clustering of disease features was assessed using contingency table analysis and Pearson correlation coefficients. Multivariate logistic and linear regression analyses were used to account for other characteristics that might influence familial clustering, such as disease duration, sex, and age at diagnosis.
RESULTS: Several disease characteristics exhibited significant familial clustering, including seropositivity (multivariate odds ratio [OR] 4.3, P < 0.0001), nodules (OR 2.3, P < 0.0001), and age at RA diagnosis (multivariate regression coefficient [beta] 0.44, P < 0.0001). Other characteristics demonstrated statistically significant but modest degrees of familial clustering (Joint Alignment and Motion score, Health Assessment Questionnaire score, and year of RA diagnosis) or modest but nonsignificant familial clustering (other extraarticular manifestations, other autoimmune diseases).
CONCLUSION: The clustering of certain disease characteristics implicates specific genetic or nongenetic causes. These results highlight the importance of considering disease phenotype in future genetic and epidemiologic studies of RA.

Entities:  

Mesh:

Year:  2004        PMID: 15022313     DOI: 10.1002/art.20066

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  30 in total

1.  Evidence for interaction between 5-hydroxytryptamine (serotonin) receptor 2A and MHC type II molecules in the development of rheumatoid arthritis.

Authors:  Maria Seddighzadeh; Marina Korotkova; Henrik Källberg; Bo Ding; Nina Daha; Fina A S Kurreeman; Rene E M Toes; Tom W Huizinga; Anca I Catrina; Lars Alfredsson; Lars Klareskog; Leonid Padyukov
Journal:  Eur J Hum Genet       Date:  2010-02-24       Impact factor: 4.246

2.  Genes and autoimmune diseases - a complex inheritance.

Authors:  Sara M Mariani
Journal:  MedGenMed       Date:  2004-12-08

3.  Two independent alleles at 6q23 associated with risk of rheumatoid arthritis.

Authors:  Robert M Plenge; Chris Cotsapas; Leela Davies; Alkes L Price; Paul I W de Bakker; Julian Maller; Itsik Pe'er; Noel P Burtt; Brendan Blumenstiel; Matt DeFelice; Melissa Parkin; Rachel Barry; Wendy Winslow; Claire Healy; Robert R Graham; Benjamin M Neale; Elena Izmailova; Ronenn Roubenoff; Alexander N Parker; Roberta Glass; Elizabeth W Karlson; Nancy Maher; David A Hafler; David M Lee; Michael F Seldin; Elaine F Remmers; Annette T Lee; Leonid Padyukov; Lars Alfredsson; Jonathan Coblyn; Michael E Weinblatt; Stacey B Gabriel; Shaun Purcell; Lars Klareskog; Peter K Gregersen; Nancy A Shadick; Mark J Daly; David Altshuler
Journal:  Nat Genet       Date:  2007-11-04       Impact factor: 38.330

4.  Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes.

Authors:  Lindsey A Criswell; Kirsten A Pfeiffer; Raymond F Lum; Bonnie Gonzales; Jill Novitzke; Marlena Kern; Kathy L Moser; Ann B Begovich; Victoria E H Carlton; Wentian Li; Annette T Lee; Ward Ortmann; Timothy W Behrens; Peter K Gregersen
Journal:  Am J Hum Genet       Date:  2005-02-17       Impact factor: 11.025

Review 5.  Family history of rheumatoid arthritis: an old concept with new developments.

Authors:  Thomas Frisell; Saedis Saevarsdottir; Johan Askling
Journal:  Nat Rev Rheumatol       Date:  2016-04-21       Impact factor: 20.543

6.  PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis.

Authors:  Victoria E H Carlton; Xiaolan Hu; Anand P Chokkalingam; Steven J Schrodi; Rhonda Brandon; Heather C Alexander; Monica Chang; Joseph J Catanese; Diane U Leong; Kristin G Ardlie; Daniel L Kastner; Michael F Seldin; Lindsey A Criswell; Peter K Gregersen; Ellen Beasley; Glenys Thomson; Christopher I Amos; Ann B Begovich
Journal:  Am J Hum Genet       Date:  2005-08-10       Impact factor: 11.025

Review 7.  The MHC2TA -168A/G polymorphism and risk for rheumatoid arthritis: a meta-analysis of 6861 patients and 9270 controls reveals no evidence for association.

Authors:  P G Bronson; L A Criswell; L F Barcellos
Journal:  Ann Rheum Dis       Date:  2007-09-17       Impact factor: 19.103

8.  A towards-multidimensional screening approach to predict candidate genes of rheumatoid arthritis based on SNP, structural and functional annotations.

Authors:  Liangcai Zhang; Wan Li; Leilei Song; Lina Chen
Journal:  BMC Med Genomics       Date:  2010-08-20       Impact factor: 3.063

9.  Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development.

Authors:  Anouk L Feitsma; Jane Worthington; Annette H M van der Helm-van Mil; Darren Plant; Wendy Thomson; Jennie Ursum; Dirkjan van Schaardenburg; Irene E van der Horst-Bruinsma; Jon J van Rood; Tom W J Huizinga; René E M Toes; René R P de Vries
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

Review 10.  Challenges comparing functional limitations in rheumatoid arthritis and ankylosing spondylitis.

Authors:  G H Louie; J D Reveille; M M Ward
Journal:  Clin Exp Rheumatol       Date:  2009 Jul-Aug       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.